The global Uterine Manipulation Devices Market size is expected to reach USD 373.81 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.6% from 2021 to 2028. A surge in the prevalence of gynecological diseases, coupled with the rising preference for minimally invasive surgical procedures, is a key driving factor for the market.
The increasing prevalence of various gynecological
disorders and the growing adoption of uterine manipulation devices owing to
their ease of use and convenience are among factors expected to boost the
market growth during the forecast period. The prevalence of UF tumors increases
as women grow older and it is prevalent in over 30% of women aged between 40
and 60. UF usually develops in women in their late 40s and early 50s, though in
some women it may occur at a younger age. Thus, the increasing number of women
suffering from UF has led to a rise in the number of hysterectomy procedures,
leading to significant demand for uterine manipulation devices.
Moreover, several key players are investing in R&D
for the launch of innovative minimally and noninvasive surgical instruments.
Currently, various advanced manipulators are available in the market. For
instance, during colpotomy procedure, usually manipulators with a cup to fit
over the cervix are preferred. These include RUMI in combination with KOH cups
(by CooperSurgical, Inc.) and VCare (by CONMED Corporation). Therefore, various
advantages offered by these devices are cumulatively responsible for boosting
the demand for minimally invasive procedures, thereby propelling the market
growth.
Request a free sample copy or
view report summary: Uterine Manipulation Devices Market Report
Uterine Manipulation Devices
Market Report Highlights
- In terms of application, the total laparoscopic hysterectomy (TLH)
segment held the largest share in 2020. The growing preference for
minimally invasive procedures is the major factor propelling the segment
growth
- In terms of end use, the hospitals segment held the largest revenue
share in 2020. The segment growth is majorly attributed to the increase in
the number of patients suffering from various gynecological conditions
- The Asia Pacific market is expected to witness the fastest growth
over the forecast period owing to the growing foreign investment to enter
the economically developing countries
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment